Tag Archives: Patent Law

Therasense Puts A World Of (Antitrust) Hurt On 3M

Posted on February 17, 2016 by Warren Woessner

Commentators who have declared inequitable conduct dead and buried should study TransWeb, LLC v. 3M Innovative Properties Co., App. No. 2014-1646 (Fed. Cir., Feb. 10 2016). {A copy can be found at the end of this post.] The decision demonstrates … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , , , | Leave a comment

Obama Launches Cancer Moonshot Task Force – But Where’s The Patent Power?

Posted on February 8, 2016 by Warren Woessner

On January 28, 2016, the White House issued a Memorandum establishing the Moonshot Task Force “to double the rate of progress in the fight against cancer – and put ourselves on a path to achieve in just 5 years research … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , | 2 Comments

Will Copyright Law Put Us on a Path to International Patent Exhaustion?

Posted on February 2, 2016 by Warren Woessner

This is a guest post from Theresa Stadheim of Schwegman Lundberg & Woessner. This article was first published by the American Intellectual Property Law (AIPLA) Patent Law Committee in its January 2016 newsletter.  For membership in AIPLA, visit here.  Will Copyright … Continue reading →

Posted in Miscellaneous, Uncategorized | Tagged , , , , , , , , | 1 Comment

Patents – Year In Review

Posted on February 1, 2016 by Warren Woessner

This is republished with the permission of the authors Stephen Beney, Partner, and Nicholas Aitken, Associate, Bereskin & Parr LLP, It was originally published by Bereskin & Parr LLP at www.bereskinparr.com on January 28, 2016. In 2015, Canadian courts and the Patent … Continue reading →

Posted in Canadian Practice | Tagged , , , , , , , , | Leave a comment